Dual-target inhibitors of poly (ADP-ribose) polymerase-1 for cancer therapy: Advances, challenges, and opportunities
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference161 articles.
1. The PARP superfamily;Amé;BioEssays News Rev. Mol. Cell. Dev. Biol.,2004
2. Poly(ADP-Ribosyl)Ation reactions in the regulation of nuclear functions;D'Amours;Biochem. J.,1999
3. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs;Gibson;Nat. Rev. Mol. Cell Biol.,2012
4. Nuclear ADP-ribosylation and its role in chromatin plasticity, cell differentiation, and epigenetics;Hottiger;Annu. Rev. Biochem.,2015
5. Poly(ADP-Ribosyl)Ation by PARP1: reaction mechanism and regulatory proteins;Alemasova;Nucleic Acids Res.,2019
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy;European Journal of Medicinal Chemistry;2024-02
2. Collagen I-induced VCAN/ERK signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression;Cell Death & Disease;2024-01-24
3. Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer;European Journal of Medicinal Chemistry;2024-01
4. Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities;European Journal of Medicinal Chemistry;2023-11
5. A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies;Drug Research;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3